Medical Health Encyclopedia

Injury Disease Nutrition Poison Symptoms Surgery Test Special Topic

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nasal mucosa

Overview Symptoms Treatment Prevention

Juvenile angiofibroma

Alternative Names: Nasal tumor; Angiofibroma - juvenile; Benign nasal tumor Treatment: Treatment is required if the angiofibroma is enlarging, obstructing the airway, or causing chronic nosebleeds. In some cases, no treatment is necessary. Text Continues Below Surgical treatment includes removal of the tumor. Removal is often difficult because the tumor is unencapsulated (not enclosed) and may be deeply invasive. Recurrence of the tumor after surgical resection is common. Clotting of the vessels of the tumor (embolization) may cause the tumor to scar and stop bleeding. Embolization is performed by injecting a substance into the blood vessel to block blood flow through it. Embolization may be adequate by itself to correct the nosebleeds, or it may be followed by surgery to remove the tumor. Expectations (prognosis): Although not cancerous, angiofibromas may continue to expand. They may disappear spontaneously. There is a high rate of recurrence after surgical removal. Complications: expansion of the angiofibroma to the nose, the sinuses, and other structures anemia from chronic blood loss pressure on the brain from expansion of the angiofibroma (rare) Calling your health care provider: Call your health care provider if repeated or frequent nosebleeds occur.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2004 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.